跳至主要内容
临床试验/ACTRN12614000274673
ACTRN12614000274673已完成4 期

The effects of atropine and aminophylline premedication on respiratory problems after electroconvulsive therapy: a prospective, randomized, crossover trial

achmet ali0 个研究点目标入组 52 人开始时间: 2014年3月14日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
19 Years 至 65 Years(—)
性别
All

入选标准

  • Patients aged 19- to 65 years old with an American Society of Anesthesiologists score (ASA) of I-II who had received ECT for the first time.

排除标准

  • 1- History of ECT during the preceding 6-month period, use of nonbenzodiazepine anticonvulsants (sodium valproate, carbamazepine, lamotrigine, or topiramate), lidocaine, theophylline, or lithium during the last week. 2- Neurologic illness or severe medical illness. 3- Pregnancy 4- Morbid obesity (BMI>40). 5- Hypertension (systolic blood pressure over 160 mmHg) and /or tachycardic (>90 beats/min) patients. 6- History of stroke, brain surgery. 7- Neuromuscular disease 8-Diagnosis of pulmonary disease (COPD, asthma, bronchiectasis, etc.). 9- Patients with abnormal respiratory auscultation signs before ECT procedure.

研究者

发起方
achmet ali

相似试验